Table 1 Vaccination policies recommendations in United Kingdom, United States and World Health Organization
Characteristic/country | UK [38] | US [39] | WHO [23] |
|---|---|---|---|
Brand name | JYNNEOS | JYNNEOS and ACAM2000 | JYNNEOS and ACAM2000 |
Pre-exposure vaccination | Prioritised for GBMSM at highest risk | People with certain risk factors but without confirmed exposure | Prioritised for community at higher risk such as MSM |
Occupational vaccination | Prioritised for workers at high risk of exposure | Prioritised for workers at high risk of exposure | Prioritised for workers at high risk of exposure |
Post exposure vaccination | Within 4Â days of exposure, or up to 14Â days in those who are at higher risk of complications | Within 4Â days of exposure, or up to 14Â days | Within four days of first exposure, and up to 14Â days in the absence of symptoms |